<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01642927</url>
  </required_header>
  <id_info>
    <org_study_id>University_of_Minnesota</org_study_id>
    <nct_id>NCT01642927</nct_id>
  </id_info>
  <brief_title>Pulse Wave Analysis in Advanced Heart Failure</brief_title>
  <acronym>PWA-HF</acronym>
  <official_title>Pulse Wave Analysis in Advanced Heart Failure Patients Before and After Ventricular Assist Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A comparison of pulse wave characteristics, as measured by peripheral tonometry, in pre and
      post Left Ventricular Assist Device (LVAD) patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pulse waveforms, especially central pressure waveforms, are predictive of cardiovascular
      events. Peripheral waveforms have been correlated to central waveforms. Peripheral waveforms
      can be easily measured through applanation tonometry. In this study the investigators
      hypothesize:

        1. That previously established peripheral tonometry techniques would apply to patients with
           advanced heart failure, including continuous flow LVADs and facilitate serial evaluation
           of central hemodynamics without invasive monitoring.

        2. That temporary changes in LVAD speed will be evident in frequency spectrum analysis of
           peripheral, non-invasive waveforms.

        3. That clinical events involving LVAD will have characteristic frequency spectra.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    PI left University
  </why_stopped>
  <start_date type="Actual">February 2012</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Observation of pulse wave signatures in LVAD patients</measure>
    <time_frame>ongoing</time_frame>
  </primary_outcome>
  <number_of_groups>7</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Left Ventricular Assist Device</condition>
  <condition>Heart Failure</condition>
  <condition>Intra-aortic Balloon Pump</condition>
  <condition>LVAD Clot</condition>
  <condition>LVAD-related GI Bleed</condition>
  <arm_group>
    <arm_group_label>Intra-Aortic Balloon Pump (IABP) Group</arm_group_label>
    <description>Advanced Heart Failure and/or pre-LVAD surgical patient with IABP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IABP/LVAD Group</arm_group_label>
    <description>Post-LVAD surgical patients with IABP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Post-LVAD Group</arm_group_label>
    <description>LVAD patients 3 months or greater post-implantation undergoing echocardiography</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LVAD Event Group</arm_group_label>
    <description>LVAD patients who have developed LVAD thrombosis or GI hemorrhage related to LVAD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arrhythmia group</arm_group_label>
    <description>LVAD patient with an irregular heartbeat.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Valvular disease group</arm_group_label>
    <description>LVAD patient with valvular heart disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal control group</arm_group_label>
    <description>Healthy participant without any known heart disease (Control group).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Advanced heart failure patients, eligible for or currently treated with LVAD, outpatient
        cardiology clinic or inpatient heart failure service patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1)18 years of age or older

        2)Advanced heart failure as defined by need for IABP or LVAD

        3)One or more of the following:

          -  Current inpatient heart failure treatment with intra-aortic balloon pump (IABP)-IABP
             Group

             •≤ 1 week post-LVAD implantation with current IABP support-IABP/LVAD Group

             •≥ 3 mo post-LVAD placement and scheduled for LVAD speed optimization with
             echocardiography.-Post-LVAD Group

          -  Post-LVAD placement with suspected GI hemorrhage or LVAD thrombosis-LVAD Event Group

             4)Voluntary written informed consent before performance of any study-related procedure
             not part of normal medical care, with the understanding that consent may be withdrawn
             by the subject at any time without prejudice to future medical care.

        Exclusion Criteria:

          1. Clinical status will not permit pause of IABP (IABP and IABP/LVAD Groups)

          2. Unable to undergo echo or oversewn or patched aortic valve (Post-LVAD Group)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Eckman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Clinical and Translational Science Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Univeristy of Minnesota Lillehei Heart Institute</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 12, 2012</study_first_submitted>
  <study_first_submitted_qc>July 16, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2012</study_first_posted>
  <last_update_submitted>January 19, 2017</last_update_submitted>
  <last_update_submitted_qc>January 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>LVAD</keyword>
  <keyword>IABP</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>Thrombosis</keyword>
  <keyword>Hemorrhage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

